Massive Gastric Bleed 20 Years After Splenopneumopexy.
Abulawi A, Al-Tarbsheh AH, Bui R, Richter S.
ACG Case Rep J. 2022 Sep 1;9(9):e00862. doi: 10.14309/crj.0000000000000862. eCollection 2022 Sep.
Splenopneumopexy to treat portal hypertension produced by venous occlusive disease.
Reese JC, Fairchild RB, Brems JJ, Kaminski DL.
Arch Surg. 1992 Sep;127(9):1129-32. doi: 10.1001/archsurg.1992.01420090141021.
Splenopneumopexy: evaluation with splenoportography.
Zuckerman DA, Levitt RG.
J Vasc Interv Radiol. 1992 Feb;3(1):91-4. doi: 10.1016/s1051-0443(92)72196-4.
Splenopneumopexy: decompression of portal hypertension in the setting of portal venous occlusive disease.
Sutton JM, Nussbaum MS, Vu D, Diwan TS, Starnes SL, Shah SA.
Dig Dis Sci. 2015 Apr;60(4):1101-5. doi: 10.1007/s10620-014-3405-y. Epub 2014 Oct 30.
[Splenopneumopexy--for Budd-Chiari syndrome].
Akita H.
Geka Chiryo. 1968 Oct;19(4):381-8.
Prominent hepatic encephalopathy 19 years after splenopneumopexy in Budd-Chiari syndrome.
Tominaga M, Ohta M, Iwaki K, Uchida H, Endo Y, Kai S, Shibata K, Matsumoto T, Kitano S.
J Hepatobiliary Pancreat Surg. 2007;14(2):200-3. doi: 10.1007/s00534-006-1131-3. Epub 2007 Mar 27.
Portopulmonary shunt by splenopneumopexy for portal hypertension in children.
Sakoda K, Ono J, Kawada T, Katsuki T, Akita H.
J Pediatr Surg. 1988 Apr;23(4):323-7. doi: 10.1016/s0022-3468(88)80198-2.
Combined therapy for esophageal varices: sclerotherapy, embolization, and splenopneumopexy.
Ono J, Katsuki T, Kodama Y.
Surgery. 1987 May;101(5):535-43.
Long-term follow-up result of portopulmonary shunt by splenopneumopexy on membranous obstruction of the inferior vena cava.
Ono J, Sakoda K, Kawada T, Nishi S, Tabata M, Mizouchi J, Furukawa T, Nakamura M, Wada T, Katsuki T, et al.
Surgery. 1984 Jan;95(1):116-20.
[Splenopneumopexy and omentopneumopexy in the treatment of membranous obstruction of the inferior vena cava].
Xu PQ, Su SH, Qin BM.
Zhonghua Wai Ke Za Zhi. 1987 Sep;25(9):517-9, 555-6.
